Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Condition: Adenoid Cystic Carcinoma of the Head and Neck Interventions: Drug: OBT076; Drug: Balstilimab Sponsor: Groupe Oncologie Radiotherapie Tete et Cou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials